Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026PRNewsWire • 05/18/26
Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why24/7 Wall Street • 05/15/26
Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough PatchBarrons • 05/14/26
The Zacks Analyst Blog Meta, Pfizer, Salesforce and Smith-MidlandZacks Investment Research • 05/14/26
European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With InhibitorsBusiness Wire • 05/13/26
Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)GlobeNewsWire • 05/12/26
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?24/7 Wall Street • 05/11/26
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?The Motley Fool • 05/09/26